Rapid Rx Quiz: Semaglutide

Mary L. Windle, PharmD


January 20, 2022

Called a "game changer" weight loss drug by some experts, semaglutide is the first such medication approved by the US Food and Drug Administration since 2014. Semaglutide, specifically the brand Wegovy, is indicated for use in adults with obesity or overweight and at least one weight-related condition (such as type 2 diabetes, high blood pressure, or high cholesterol). The drug should be used in tandem with increased physical activity and a reduced-calorie diet.

Given semaglutide's potential to help reduce serious weight-related conditions, knowledge regarding related clinical issues is essential. Do you know best practices for semaglutide, as well as interactions to avoid and adverse effects to watch for? Test yourself on this promising new drug with this short quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.